SSY Group Limited (HKG:2005)

Market Cap	9.30B
Revenue (ttm)	5.77B
Net Income (ttm)	1.06B
Shares Out	2.94B
EPS (ttm)	0.36
PE Ratio	8.82
Forward PE	7.96
Dividend	0.18 (5.63%)
Ex-Dividend Date	May 20, 2025

Volume	16,098,000
Average Volume	11,889,435
Open	3.160
Previous Close	3.110
Day's Range	3.090 - 3.170
52-Week Range	2.580 - 4.670
Beta	0.64
RSI	70.36
Earnings Date	Aug 28, 2025

About SSY Group

SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceuti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 6,146
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2005

Financial Performance

In 2024, SSY Group's revenue was 5.77 billion, a decrease of -10.67% compared to the previous year's 6.46 billion. Earnings were 1.06 billion, a decrease of -19.53%.